OPDIVO 10 mg/mL concentrate for solution for infusion., YERVOY 5 mg/ml concentrate for solution for infusion
Phase 2 small_molecule active
Quick answer
OPDIVO 10 mg/mL concentrate for solution for infusion., YERVOY 5 mg/ml concentrate for solution for infusion for Unresectable locally advanced or metastatic urothelial cancer is a Phase 2 program (small_molecule) at Tour Hekla with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tour Hekla
- Indication
- Unresectable locally advanced or metastatic urothelial cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active